Skip to content

ALNYLAM PHARMACEUTICALS, INC.: filings

Every ALNYLAM PHARMACEUTICALS, INC. annual and quarterly report in the SEC record with the published financial measures it tagged, 64 filings, each linked to its SEC index.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2026-07-30fiscal Q2 2026451290001178670-26-000062
10-K2026-02-12fiscal FY 2025511560001628280-26-007497
10-Q2025-10-30fiscal Q3 2025451330001628280-25-047345
10-Q2025-07-31fiscal Q2 2025451290001178670-25-000090
10-Q2025-05-01fiscal Q1 202545950001178670-25-000052
10-K2025-02-13fiscal FY 2024511340001178670-25-000026
10-Q2024-10-31fiscal Q3 2024431290001178670-24-000053
10-Q2024-08-01fiscal Q2 2024431250001178670-24-000041
10-Q2024-05-02fiscal Q1 202443910001178670-24-000023
10-K2024-02-15fiscal FY 2023501300001178670-24-000008
10-Q2023-11-02fiscal Q3 2023431290001178670-23-000023
10-Q2023-08-03fiscal Q2 2023431250001178670-23-000015
10-Q2023-05-04fiscal Q1 202343910001178670-23-000011
10-K2023-02-23fiscal FY 2022501290001178670-23-000005
10-Q2022-10-27fiscal Q3 2022431290001178670-22-000026
10-Q2022-07-28fiscal Q2 2022451290001178670-22-000020
10-Q2022-04-28fiscal Q1 202243890001178670-22-000016
10-K2022-02-10fiscal FY 2021511320001178670-22-000013
10-Q2021-10-28fiscal Q3 2021431270001178670-21-000028
10-Q2021-08-03fiscal Q2 2021431230001178670-21-000024
10-Q2021-04-29fiscal Q1 202139810001178670-21-000017
10-K2021-02-11fiscal FY 2020461330001178670-21-000010
10-Q2020-11-05fiscal Q3 2020391110001178670-20-000019
10-Q2020-08-06fiscal Q2 2020401090001178670-20-000015
10-Q2020-05-06fiscal Q1 202039810001178670-20-000007
10-K2020-02-13fiscal FY 2019461330001178670-20-000004
10-Q2019-10-31fiscal Q3 2019411120001178670-19-000005
10-Q2019-08-06fiscal Q2 2019411040001564590-19-029367
10-Q2019-05-02fiscal Q1 201941820001564590-19-015366
10-K2019-02-14fiscal FY 2018441220001564590-19-003022
10-Q2018-11-07fiscal Q3 201838920001564590-18-028070
10-Q2018-08-02fiscal Q2 201835900001564590-18-018696
10-Q2018-05-04fiscal Q1 201830630001564590-18-011031
10-K2018-02-15fiscal FY 201731950001564590-18-002152
10-Q2017-11-07fiscal Q3 201728730001564590-17-022281
10-Q2017-08-09fiscal Q2 201728730001564590-17-016993
10-Q2017-05-05fiscal Q1 201727560001564590-17-008948
10-K2017-02-15fiscal FY 2016331000001564590-17-001649
10-Q2016-11-03fiscal Q3 201628730001193125-16-758802
10-Q2016-08-04fiscal Q2 201629770001193125-16-671945
10-Q2016-05-04fiscal Q1 201629580001193125-16-577773
10-K2016-02-12fiscal FY 2015341020001193125-16-462538
10-Q2015-11-09fiscal Q3 201527730001193125-15-371063
10-Q2015-08-07fiscal Q2 201527730001193125-15-282067
10-Q2015-05-08fiscal Q1 201527540001193125-15-178432
10-K2015-02-13fiscal FY 2014321000001193125-15-050223
10-Q2014-11-06fiscal Q3 201428750001193125-14-399866
10-Q2014-08-08fiscal Q2 201428750001193125-14-301873
10-Q2014-05-09fiscal Q1 201428560001193125-14-192579
10-K2014-02-20fiscal FY 2013351090001193125-14-060913
10-Q2013-11-07fiscal Q3 201331820001193125-13-431609
10-Q2013-08-09fiscal Q2 201331820001193125-13-328105
10-Q2013-05-07fiscal Q1 201331630001193125-13-204676
10-K2013-02-19fiscal FY 2012361080001193125-13-065475
10-Q2012-11-05fiscal Q3 201231770001193125-12-452123
10-Q2012-08-08fiscal Q2 201231800001193125-12-344262
10-Q2012-05-03fiscal Q1 201231630001193125-12-208797
10-K2012-02-13fiscal FY 201133860001193125-12-053552
10-Q2011-11-03fiscal Q3 201132810000950123-11-094900
10-Q2011-08-03fiscal Q2 201132810000950123-11-071950
10-Q2011-05-05fiscal Q1 201130610000950123-11-045184
10-K2011-02-18fiscal FY 201034890000950123-11-015737
10-Q2010-11-04fiscal Q3 201030800000950123-10-101051
10-Q2010-08-05fiscal Q2 201032840000950123-10-073454

Inspect the source

Entity
ALNYLAM PHARMACEUTICALS, INC. / CIK 0001178670
Captured
2026-09-20T07:45:03.960Z
SEC response SHA-256
bd72ebc4b5a116f8e743e4d6f33178d8af2533ff852a0cd94d52307715b0cbd0

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001178670.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))